Related Experiment Video
Updated: Apr 21, 2026
07:20
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.1K
Interleukin-7 and interleukin-15 for cancer
Paul Zarogoulidis1, Sofia Lampaki1, Lonny Yarmus2
11. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Journal of Cancer
|November 5, 2014
Summary
Interleukin 7 and 15 (IL-7 and IL-15) are pro-inflammatory cytokines that can destabilize chromosomes and promote cancer. Their role in influencing the tumor microenvironment and immune system is key to understanding immunotherapy.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Interleukin 7 and 15 (IL-7 and IL-15) are potent pro-inflammatory cytokines.
- These cytokines possess the ability to destabilize chromosomes, a known factor in tumorigenesis.
- IL-7 and IL-15 play a crucial role in regulating malignancy proliferation via the tumor microenvironment and immune system.
Purpose of the Study:
- To investigate the role of Interleukin 7 and 15 in cancer development and progression.
- To explore the mechanisms by which IL-7 and IL-15 influence the tumor microenvironment and immune response.
- To understand the potential of IL-7 and IL-15 as therapeutic targets in immunotherapy.
Main Methods:
- Review of existing literature on IL-7 and IL-15 in cancer.
- Analysis of cytokine signaling pathways involved in tumorigenesis.
- Examination of the impact of IL-7 and IL-15 on immune cell function within the tumor microenvironment.
Main Results:
- IL-7 and IL-15 demonstrate significant pro-inflammatory and chromosome-destabilizing effects.
- These cytokines modulate tumor microenvironment and immune system components, influencing cancer cell proliferation.
- Extensive research has focused on IL-7 and IL-15 in hematological malignancies due to their direct immune-stimulating effects.
Conclusions:
- Interleukin 7 and 15 are critical players in cancer biology, impacting chromosomal stability and proliferation.
- Understanding the intricate mechanisms of IL-7 and IL-15 is essential for advancing immunotherapy strategies.
- Further investigation into IL-7 and IL-15 is warranted, particularly in hematological malignancies and other cancer types.
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:24T Cell Types and Functions
3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:19Psychoneuroimmunology: Diabetes and Cancer
520
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
520
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K